Cancer patients with cardiovascular disease have survival rates comparable to cancer patients within the age-cohort of 10 years older without cardiovascular morbidity

Critical Reviews in Oncology/Hematology

Volumn 76, Issue 3, 2010, Pages 196-207

  Janssen Heijnen, Maryska L G ^a,b   Szerencsi, Karolina ^a   van de Schans, Saskia A M ^a   Maas, Huub A A M ^c   Widdershoven, Jos W ^c   Coebergh, Jan Willem W ^a,b  

^a Eindhoven Cancer Registry ^*  (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

Author keywords

Cancer; Cardiovascular diseases; Comorbidity; Population based; Prevelance; Prognosis; Treatment

Indexed keywords

ADULT; AGED; AGING; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COLON CANCER; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; ELDERLY CARE; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; OUTCOMES RESEARCH; POPULATION RESEARCH; PRACTICE GUIDELINE; PREVALENCE; PROGNOSIS; PROSTATE CANCER; RECTUM CANCER; REVIEW; RISK ASSESSMENT; SURVIVAL RATE;

AGE FACTORS; AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 78149411298     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2009.11.004     Document Type: Review

References (50)

1. Janssen-Heijnen M.L., Houterman S., Lemmens V.E., Louwman M.W., Maas H.A., Coebergh J.W. Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol 2005, 55:231-240.
2. Signaleringscommissie Kanker Kanker in Nederland: Trends, Prognoses en Implicaties Voor Zorgvraag 2004, KWF Kankerbestrijding, Amsterdam.
3. Driver J.A., Djousse L., Logroscino G., Gaziano J.M., Kurth T. Incidence of cardiovascular disease and cancer in advanced age: prospective cohort study. BMJ 2008, 337:a2467.
4. Fowler J.E., Terrell F.L., Renfroe D.L. Co-morbidities and survival of men with localized prostate cancer treated with surgery or radiation therapy. J Urol 1996, 156:1714-1718.
5. Hall W.H., Jani A.B., Ryu J.K., Narayan S., Vijayakumar S. The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancer. Prostate Cancer Prostatic Dis 2005, 8:22-30.
6. Marr P.L., Elkin E.P., Arredondo S.A., Broering J.M., DuChane J., Carroll P.R. Comorbidity and primary treatment for localized prostate cancer: data from CaPSURE. J Urol 2006, 175:1326-1331.
7. Otto S.J., Schroder F.H., de Koning H.J. Risk of cardiovascular mortality in prostate cancer patients in the Rotterdam randomized screening trial. J Clin Oncol 2006, 24:4184-4189.
8. Satariano W.A., Ragland K.E., Van Den Eeden S.K. Cause of death in men diagnosed with prostate carcinoma. Cancer 1998, 83:1180-1188.
9. Schwartz K.L., Alibhai S.M., Tomlinson G., Naglie G., Krahn M.D. Continued undertreatment of older men with localized prostate cancer. Urology 2003, 62:860-865.
10. Hall H.I., Satariano W.A., Thompson T., Ragland K.E., Van Den Eeden S.K., Selvin S. Initial treatment for prostate carcinoma in relation to comorbidity and symptoms. Cancer 2002, 95:2308-2315.
11. Houterman S., Janssen-Heijnen M.L., Hendrikx A.J., van den Berg H.A., Coebergh J.W. Impact of comorbidity on treatment and prognosis of prostate cancer patients: a population-based study. Crit Rev Oncol Hematol 2006, 58:60-67.
12. Bouchardy C., Rapiti E., Blagojevic S., Vlastos A.T., Vlastos G. Older female cancer patients: importance, causes, and consequences of undertreatment. J Clin Oncol 2007, 25:1858-1869.
13. Cronin-Fenton D.P., Norgaard M., Jacobsen J., et al. Comorbidity and survival of Danish breast cancer patients from 1995 to 2005. Br J Cancer 2005, 2007.
14. Giordano S.H., Hortobagyi G.N., Kau S.W., Theriault R.L., Bondy M.L. Breast cancer treatment guidelines in older women. J Clin Oncol 2005, 23:783-791.
15. Houterman S., Janssen-Heijnen M.L., Verheij C.D., et al. Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients. Br J Cancer 2004, 90:2332-2337.
16. Hurria A., Naeim A., Elkin E., et al. Adjuvant treatment recommendations in older women with breast cancer: a survey of oncologists. Crit Rev Oncol Hematol 2007, 61:255-260.
17. Yancik R., Wesley M.N., Ries L.A., Havlik R.J., Edwards B.K., Yates J.W. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 2001, 285:885-892.
18. Ballard-Barbash R., Potosky A.L., Harlan L.C., Nayfield S.G., Kessler L.G. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst 1996, 88:716-726.
19. Nagel G., Wedding U., Rohrig B., Katenkamp D. The impact of comorbidity on the survival of postmenopausal women with breast cancer. J Cancer Res Clin Oncol 2004, 130:664-670.
20. Gross C.P., McAvay G.J., Guo Z., Tinetti M.E. The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer. Cancer 2007, 109:2410-2419.
21. Lemmens V.E., Janssen-Heijnen M.L., Verheij C.D., Houterman S., Repelaer van Driel O.J., Coebergh J.W. Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. Br J Surg 2005, 92:615-623.
22. Lemmens V.E., van Halteren A.H., Janssen-Heijnen M.L., Vreugdenhil G., Repelaer van Driel O.J., Coebergh J.W. Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity. Ann Oncol 2005, 16:767-772.
23. Rieker R.J., Hammer E., Eisele R., Schmid E., Hogel J. The impact of comorbidity on the overall survival and the cause of death in patients after colorectal cancer resection. Langenbecks Arch Surg 2002, 387:72-76.
24. Ambrogi V., Pompeo E., Elia S., Pistolese G.R., Mineo T.C. The impact of cardiovascular comorbidity on the outcome of surgery for stage I and II non-small-cell lung cancer. Eur J Cardiothorac Surg 2003, 23:811-817.
25. Dy S.M., Sharkey P., Herbert R., Haddad K., Wu A.W. Comorbid illnesses and health care utilization among medicare beneficiaries with lung cancer. Crit Rev Oncol Hematol 2006, 59:218-225.
26. Townsley C.A., Selby R., Siu L.L. Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials. J Clin Oncol 2005, 23:3112-3124.
27. Schouten L.J., Hoppener P., van den Brandt P.A., Knottnerus J.A., Jager J.J. Completeness of cancer registration in Limburg, The Netherlands. Int J Epidemiol 1993, 22:369-376.
28. Schram M.T., Frijters D., van de Lisdonk E.H., et al. Setting and registry characteristics affect the prevalence and nature of multimorbidity in the elderly. J Clin Epidemiol 2008, 28.
29. Ambrose J.A., Barua R.S. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 2004, 43:1731-1737.
30. Kushi L., Giovannucci E. Dietary fat and cancer. Am J Med 2002, 113(Suppl. 9B):63S-70S.
31. Larsson S.C., Rutegard J., Bergkvist L., Wolk A. Physical activity, obesity, and risk of colon and rectal cancer in a cohort of Swedish men. Eur J Cancer 2006, 42:2590-2597.
32. Ross J.S., Stagliano N.E., Donovan M.J., Breitbart R.E., Ginsburg G.S. Atherosclerosis and cancer: common molecular pathways of disease development and progression. Ann N Y Acad Sci 2001, 947:271-292. discussion 92-3.
33. Fokkema M.R., Muskiet F.A., van Doormaal J.J. Lifestyle intervention for the prevention of cardiovascular disease. Ned Tijdschr Geneeskd 2005, 149:2607-2612.
34. Read W.L., Tierney R.M., Page N.C., et al. Differential prognostic impact of comorbidity. J Clin Oncol 2004, 22:3099-3103.
35. Vulto A.J., Lemmens V.E., Louwman M.W., et al. The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands, 1995 to 2002. Cancer 2006, 106:2734-2742.
36. Fleming S.T., Pursley H.G., Newman B., Pavlov D., Chen K. Comorbidity as a predictor of stage of illness for patients with breast cancer. Med Care 2005, 43:132-140.
37. Gonzalez E.C., Ferrante J.M., Van Durme D.J., Pal N., Roetzheim R.G. Comorbid illness and the early detection of cancer. South Med J 2001, 94:913-920.
38. Lemmens V.E., Janssen-Heijnen M.L., Houterman S., et al. Which comorbid conditions predict complications after surgery for colorectal cancer?. World J Surg 2007, 31:192-199.
39. Mangano D.T. Perioperative cardiac morbidity. Anesthesiology 1990, 72:153-184.
40. van de Schans S.A., Janssen-Heijnen M.L., Biesma B., et al. COPD in cancer patients: higher prevalence in the elderly, a different treatment strategy in case of primary tumours above the diaphragm, and a worse overall survival in the elderly patient. Eur J Cancer 2007, 43:2194-2202.
41. Janssen-Heijnen M.L., Lemmens V.E., van den Borne B.E., Biesma B., Oei S.B., Coebergh J.W. Negligible influence of comorbidity on prognosis of patients with small cell lung cancer: a population-based study in the Netherlands. Crit Rev Oncol Hematol 2007, 62:172-178.
42. Ludbrook J.J., Truong P.T., MacNeil M.V., et al. Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? A community-based population analysis. Int J Radiat Oncol Biol Phys 2003, 55:1321-1330.
43. Pignon J.P., Arriagada R., Ihde D.C., et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 1992, 327:1618-1624.
44. Gridelli C., Langer C., Maione P., Rossi A., Schild S.E. Lung cancer in the elderly. J Clin Oncol 2007, 25:1898-1907.
45. Socinski M.A., Bogart J.A. Limited-stage small-cell lung cancer: the current status of combined-modality therapy. J Clin Oncol 2007, 25:4137-4145.
46. Warde P., Payne D. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 1992, 10:890-895.
47. Smith B.D., Gross C.P., Smith G.L., Galusha D.H., Bekelman J.E., Haffty B.G. Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Inst 2006, 98:681-690.
48. Peeters A., Mamun A.A., Willekens F., Bonneux L. A cardiovascular life history. A life course analysis of the original Framingham Heart Study cohort. Eur Heart J 2002, 23:458-466.
49. Froehner M., Koch R., Litz R., Oehlschlaeger S., Wirth M.P. Which conditions contributing to the Charlson score predict survival after radical prostatectomy?. J Urol 2004, 171:697-699.
50. Schairer C., Mink P.J., Carroll L., Devesa S.S. Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst 2004, 96:1311-1321.